Skip to content
Home/Companies/Biotech/Concinnity Genetics
Concinnity Genetics

Concinnity Genetics

Biotech·UK·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Concinnity Genetics?

Concinnity Genetics is currently owned by Old College Capital through Old College Capital LP (2011 vintage), since 2024.

Hand-verified · updated 2026-07-08

Old College Capital
Investor
Old College Capital
Old College Capital LP · 2011 · Evergreen

Key facts

HQUK
SectorBiotech
StatusActive
Websitewww.concinnitygenetics.com

More from Old College Capital LP

Other portfolio companies in the same fund.

Javelo Health
Active
Terrapin Finance
Active
Forge Minerals
Forge Minerals
Active
ClimateTechUK· 2026
VerbaFlo
Active
PropTechUK· 2026
Forth Therapeutics
Forth Therapeutics
Active
PharmaUK· 2025
Exergy3
Active
ClimateTechUK· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Concinnity Genetics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Concinnity Genetics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Concinnity Genetics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue